# REMIssion of Type 2 Diabetes Between Intermittently Scanned Continuous Glucose Monitoring and Capillary Blood Glucose Monitoring When Added to Low-calorie Meal Replacement and Diabetes Self-management Education

Study · id `cardio:ct-nct07157384` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07157384](<https://clinicaltrials.gov/study/NCT07157384>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07157384

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 176 participants.

## Technical summary

Registry record NCT07157384. Randomized; no masking; primary purpose treatment. Start 2025-09 (anticipated); primary completion 2027-03 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 176 participants (planned count; ClinicalTrials.gov record NCT07157384, source copy `cardio:ctgov-nct07157384-2025-09-05`, retrieved 2026-10-26)
- Planned start: 2025-09 (anticipated) (ClinicalTrials.gov record NCT07157384, source copy `cardio:ctgov-nct07157384-2025-09-05`, retrieved 2026-10-26)
- Primary completion: 2027-03 (anticipated) (ClinicalTrials.gov record NCT07157384, source copy `cardio:ctgov-nct07157384-2025-09-05`, retrieved 2026-10-26)
- Completion: 2027-06 (anticipated) (ClinicalTrials.gov record NCT07157384, source copy `cardio:ctgov-nct07157384-2025-09-05`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT07157384, source copy `cardio:ctgov-nct07157384-2025-09-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07157384-2025-09-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: REMIssion of Type 2 Diabetes Between Intermittently Scanned Continuous Glucose Monitoring and Capillary Blood Glucose Monitoring When Added to Low-calorie Meal Replacement and Diabetes Self-management Education
- Acronym: REMIT2D isCGM
- Condition: Type 2 Diabetes
- Intervention (Dietary supplement): Low calorie meal replacement plan
- Intervention (Behavioral): Diabetes self management education
- Intervention (Device): Intermittently scanned continuous glucose monitoring
- Intervention (Device): capillary blood glucose monitoring
- Lead sponsor: LMC Diabetes & Endocrinology Ltd.
- Lead sponsor class: OTHER
- Collaborator: Abbott Diabetes Care
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: LMC Diabetes & Endocrinology Ltd. (`cardio:org-lmc-diabetes-endocrinology-ltd`)
- Registry lists this organization as a collaborator: Abbott Diabetes Care (`cardio:org-abbott-diabetes-care`)

## Provenance

Content hash: f815b6cb00d6be1e678444b85195db7c04001f473d686652d667a0af4ff614dd
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
